| |||||||||||
ICBT 2013 : International Conference on Biomedical Technology | |||||||||||
Link: http://sfb599.de/index.php?id=introduction | |||||||||||
| |||||||||||
Call For Papers | |||||||||||
CALL FOR ABSTRACTS You are invited to submit an abstract for a symposium on the theme of TRANSPORT PROCESSES ASSOCIATED WITH DISEASE & TREATMENT, organised for the next ECCOMAS Thematic Conference - International Conference on Biomedical Technology (ICBT13), to be held in Hannover, Germany, between 20-22 November 2013. For more details, consult the conference website. DEADLINE FOR ABSTRACT SUBMISSION IS 22 SEPTEMBER 2013 Abstract can be submitted online at http://sfb599.de/index.php?id=abstractsubmission. A special volume will appear in a Springer Lecture Note series. If authors like to submit a full paper, the conference organisers will be please to accept papers for this special issue. --- CONTACTS (SYMPOSIUM) --- If you are interested to submit an abstract for this symposium, you are advised to contact the symposium organisers: e.boileau@swansea.ac.uk or p.nithiarasu@swansea.ac.uk. Please note that symposium organisers are not responsible for the organisation of this event. PROPOSAL Modelling of transport processes often requires a systems biology approach to facilitate the integration of the many different scales involved, ranging from the macroscopic level to the cellular and sub-cellular levels. This mini-symposium focuses on two major trends: (i) transport processes involved in disease development & progression and (ii) transport mechanisms associated with implantable medical devices, and requirements such as biocompatibility, mechanical and chemical integrity. Contributions from both theoretical/fundamental/computational advances and applied research are welcome, and the topics are not limited to the ones mentioned in this proposal. TOPICS INCLUDE BUT ARE NOT LIMITED TO: * Mass transport (oxygen, LDL, and other chemical species) associated with atherosclerosis development and progression. * Processes involved in plaque rupture, growth and rupture of cerebral aneurysms. * The role of purinergic signalling in endothelium-mediated vasodilation. * Implantable devices: implantable active drug administration devices, indwelling chemical sensors or tissue engineered constructs. * Kinetics of mass transfer and the regeneration of tissue components. * Modelling of tissue responses to implants. * Drug-eluting stents. |
|